DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia

Information source: University of California, San Diego
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Pain; Hyperalgesia

Intervention: Lidoderm Patch (Drug)

Phase: Phase 1

Status: Completed

Sponsored by: University of California, San Diego

Official(s) and/or principal investigator(s):
Mark S. Wallace, MD, Principal Investigator, Affiliation: University of California, San Diego


To determine the effects of Lidocaine patch on the pain and hyperalgesia induced by intradermal capsaicin

Clinical Details

Official title: Effects of Lidocaine Patch on Intradermal Capsaicin Induced Pain and Hyperalgesia

Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Primary outcome:

Neurosensory testing

Four neurosensory tests: warm and cold sensation,warm/cold pain/touch/mechanical pain.

Warm and cold sensation measured w/a Thermal Sensory

Touch will be measured using von Frey hairs. Calibrated von Frey hairs are filaments of varying size. The filament are selected at random and 3 successive stimuli are applied for 1.5 second at 5 second intervals per filament

Mechanical pain will be measured using von Frey hairs. Endpoint will be pain.

Secondary outcome:

Allodynia and Hyperalgesia

At the completion of the stimulation, areas of cutaneous allodynia and hyperalgesia will be mapped. The region of hyperalgesia will be established with a 5.18 von Frey hair, and the area of allodynia with a foam brush gently stroked on the skin.

Detailed description: A randomized, double-blinded, placebo controlled methodology will be conducted. At the session subjects will be exposed to placebo patch and lidocaine patch. Prior to study drug administration, a baseline neurosensory test on the volar aspect of both forearms will be performed and baseline vital signs will be measured. A placebo patch and a lidocaine patch will then be applied to the volar aspect of each forearm. The arms will be randomized to which arm receives placebo and which one receives the lidocaine patch. After four hours of application the right forearm patch will be removed the neurosensory testing will be repeated on the right forearm. After completing the testing, capsaicin (10┬Ál, 10 mg/ml) will be injected intradermally on the volar aspect of the right forearm. Elicited and spontaneous pain scores, blood pressure, heart rate, and respiratory rate will be measured at the time of injection and every 2. 5 minutes for 10 minutes. A McGill Pain Questionnaire will be administered at the time of capsaicin injection only. Ten minutes after the capsaicin injection, the hyperalgesic area will be established to von Frey hair, stroking, and heat; the flare response will be outlined; and neurosensory testing will performed halfway between the edge of this defined area and the capsaicin injection site. At the completion of the testing on the right forearm, the left forearm patch will be removed and the procedures described for the right forearm will be repeated for the left forearm.


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Age 18 and above

Exclusion Criteria:

- Pregnancy.

- Allergy to lidocaine

- Current painful condition

- Current use of analgesics for the treatment of pain

- Lack of ability to understand the experimental protocol and to adequately communicate

in English. The neurosensory testing we plan to perform requires the complete cooperation and understanding of the subject. It would be impossible to perform these studies on patients who do not adequately communicate in English.

Locations and Contacts

UCSD Center for Pain and Palliative Care, La Jolla, California 92037, United States
Additional Information

Related publications:

Wallace MS, Laitin S, Licht D, Yaksh TL. Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology. 1997 Jun;86(6):1262-72.

Wallace, M.S., et al., Concentration-effect relationship for intravenous alfentanil and ketamine infusions in human volunteers: Effects upon acute sensory thresholds and capsaicin evoked hyperpathia. J Pain, 2001. 2: p. A646.

Ando K, Wallace MS, Braun J, Schulteis G. Effect of oral mexiletine on capsaicin-induced allodynia and hyperalgesia: a double-blind, placebo-controlled, crossover study. Reg Anesth Pain Med. 2000 Sep-Oct;25(5):468-74.

Eisenach JC, Hood DD, Curry R, Tong C. Alfentanil, but not amitriptyline, reduces pain, hyperalgesia, and allodynia from intradermal injection of capsaicin in humans. Anesthesiology. 1997 Jun;86(6):1279-87.

Eisenach JC, Hood DD, Curry R. Intrathecal, but not intravenous, clonidine reduces experimental thermal or capsaicin-induced pain and hyperalgesia in normal volunteers. Anesth Analg. 1998 Sep;87(3):591-6.

Cervero F, Gilbert R, Hammond RG, Tanner J. Development of secondary hyperalgesia following non-painful thermal stimulation of the skin: a psychophysical study in man. Pain. 1993 Aug;54(2):181-9.

Starting date: December 2005
Last updated: September 7, 2006

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017